During the course of our experiments, we noticed that HNSCC cell lines expressed the RANKL receptor RANK (Fig. 4a) as abundantly as the PC3 and LNCaP cell lines from prostate cancer bone metastases, which are known to express this molecule28, 29. This evidence concerns the gene TNFRSF11A and head and neck squamous cell carcinoma.